Similar Articles
461 Laparoscopic vs open liver re-resection for cirrhotic patients with post-hepatectomy hepatocellular carcinoma recurrence: A comparative study
462 Providing higher value care for hepatocellular carcinoma rather than diagnosis: What can current radiologists do?
463 Role of hepatitis B virus in development of hepatocellular carcinoma: Focus on covalently closed circular DNA
464 Emerging curative-intent minimally-invasive therapies for hepatocellular carcinoma
465 Loco-regional treatment of hepatocellular carcinoma: Role of contrast-enhanced ultrasonography
466 Impact of COVID-19 pandemic on clinicopathological features of transplant recipients with hepatocellular carcinoma: A case-control study
467 Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics
468 Solute carrier family 2 members 1 and 2 as prognostic biomarkers in hepatocellular carcinoma associated with immune infiltration
469 Is there a role for liver transplantation in the treatment of hepatocellular carcinoma in non-cirrhotic liver?
470 Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA